Your browser doesn't support javascript.
loading
Interleukin-3 stabilizes CD124/IL-4α surface expression in mast cells via Tyk2 and STAT6.
Drube, Sebastian; Strotmann, Birgit; Wegner, Philine; Jäger, Ute-Maria; Küchler, Claudia; Andreas, Nico.
Afiliação
  • Drube S; Institute of Immunology, Universitätsklinikum Jena, Friedrich-Schiller-Universität Jena, Jena, Germany.
  • Strotmann B; Institute of Immunology, Universitätsklinikum Jena, Friedrich-Schiller-Universität Jena, Jena, Germany.
  • Wegner P; Institute of Immunology, Universitätsklinikum Jena, Friedrich-Schiller-Universität Jena, Jena, Germany.
  • Jäger UM; Institute of Immunology, Universitätsklinikum Jena, Friedrich-Schiller-Universität Jena, Jena, Germany.
  • Küchler C; Institute of Immunology, Universitätsklinikum Jena, Friedrich-Schiller-Universität Jena, Jena, Germany.
  • Andreas N; Institute of Immunology, Universitätsklinikum Jena, Friedrich-Schiller-Universität Jena, Jena, Germany.
Immunology ; 169(1): 102-112, 2023 05.
Article em En | MEDLINE | ID: mdl-36440951
ABSTRACT
Interleukin (IL)-4 signals can modulate mast cells, which express the IL-4Rα chain. The IL-4Rα can heterodimerise with the common γ-chain and utilizes JAK1 and JAK2 for signal transduction, while complexes of IL-4Rα with IL-13Rα1 subunit mediates signals via JAK2 and Tyk2. Here, we report that IL-3 is an essential factor for the continuous expression of the IL-4Rα chain on mast cells, which did not express the IL-13Rα1 chain. We demonstrate that the signals induced by IL-3 important for IL-4Rα expression are mediated by Tyk2 and STAT6 activation and the subsequent maintenance of HSP90 levels. In line with that, inhibition of either Tyk2, STAT6 or HSP90 impaired the IL-3-induced IL-4Rα upregulation. Consequently, the IL-3 maintained IL-4Rα surface expression via Tyk2 is essential for the costimulatory effect of IL-4 on the IL-33-induced production of IL-6 and IL-13.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Interleucina-3 / Mastócitos Idioma: En Revista: Immunology Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Alemanha

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Interleucina-3 / Mastócitos Idioma: En Revista: Immunology Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Alemanha